Arrowhead Research reported 41.67 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 56.5 26.8 Mar/2026
Merck 16.52 2.6 Mar/2026
Moderna 27.22 14.51 Jun/2023
Novartis 20.17 2.32 Mar/2026
Sarepta Therapeutics 27.27 0 Dec/2025
TG Therapeutics 10.76 2.32 Dec/2025
Vertex Pharmaceuticals 25.82 0.33 Mar/2026
Xencor 29.92 3.22 Sep/2022